{"id":332874,"date":"2026-10-29T23:10:32","date_gmt":"2026-10-29T17:40:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/sudarshan-pharma-industries-q2-results-fy27-pat-8-crore\/"},"modified":"2026-10-29T23:10:32","modified_gmt":"2026-10-29T17:40:32","slug":"sudarshan-pharma-industries-q2-results-fy27-pat-8-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sudarshan-pharma-industries-q2-results-fy27-pat-8-crore\/","title":{"rendered":"Sudarshan Pharma Industries Q2 Results FY27: PAT Jumps 86.12% to Rs 7.78 Cr, Revenue Rs 216.97 Cr, PAT Rs 7.78 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Sudarshan Pharma Industries Q2 Results FY27 were declared on 29 October 2026 for the July to September 2026 quarter. Consolidated revenue rose 28.48% YoY to Rs 216.97 Cr, while net profit climbed 86.12% YoY to Rs 7.78 Cr. This YoY growth makes the quarterly results a clear step up from Rs 168.87 Cr of revenue and Rs 4.18 Cr of net profit in the same quarter last year.<\/p>\n<\/div>\n

Sudarshan Pharma Industries Ltd<\/a> (SUDARSHAN) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brings consolidated revenue of Rs 216.97 Cr and PAT of Rs 7.78 Cr. Sudarshan Pharma Industries Q2 Results FY27 are reported on a consolidated basis, so these consolidated results are the figures used throughout this article.<\/p>\n

This results analysis of Sudarshan Pharma Industries Q2 Results covers the financial highlights, business drivers, outlook and risks. It begins with the Financial Highlights table below, and the Univest Screener lists the same quarterly numbers for readers who follow NSE and BSE listed companies.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n